Ilex Expects Priority Review For Clofarabine; Genzyme Sees Longer Timeframe

Genzyme, which is slated to acquire Ilex, apparently believes FDA may require additional data for the pediatric leukemia drug. Updated data from the two pivotal Phase II studies will be presented at the American Society of Clinical Oncology in June.